MicroTech Medical (Hangzhou) Future Growth
Future criteria checks 5/6
MicroTech Medical (Hangzhou) is forecast to grow earnings and revenue by 105% and 41% per annum respectively. EPS is expected to grow by 106.1% per annum. Return on equity is forecast to be 1.3% in 3 years.
Key information
105.0%
Earnings growth rate
106.1%
EPS growth rate
| Medical Equipment earnings growth | 40.1% |
| Revenue growth rate | 41.0% |
| Future return on equity | 1.3% |
| Analyst coverage | Low |
| Last updated | 03 Sep 2024 |
Recent future growth updates
Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22
News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 813 | 42 | -57 | -8 | 2 |
| 12/31/2025 | 581 | -9 | -108 | -40 | 2 |
| 12/31/2024 | 360 | -89 | -123 | -71 | 1 |
| 6/30/2024 | 293 | -144 | -264 | -198 | N/A |
| 3/31/2024 | 273 | -135 | -223 | -175 | N/A |
| 12/31/2023 | 253 | -125 | -182 | -153 | N/A |
| 9/30/2023 | 233 | -85 | -163 | -139 | N/A |
| 6/30/2023 | 213 | -46 | -144 | -124 | N/A |
| 3/31/2023 | 193 | -40 | -146 | -122 | N/A |
| 12/31/2022 | 174 | -35 | -149 | -119 | N/A |
| 9/30/2022 | 169 | -36 | -118 | -90 | N/A |
| 6/30/2022 | 164 | -37 | -87 | -61 | N/A |
| 3/31/2022 | 158 | -43 | -75 | -53 | N/A |
| 12/31/2021 | 151 | -48 | -63 | -44 | N/A |
| 12/31/2020 | 75 | -121 | -35 | -10 | N/A |
| 12/31/2019 | 52 | -79 | -48 | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2235 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: 2235 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2235 is expected to become profitable in the next 3 years.
Revenue vs Market: 2235's revenue (41% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 2235's revenue (41% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2235's Return on Equity is forecast to be low in 3 years time (1.3%).